Taking a nano-based medical product to the international market
|
|
- Byron Chapman
- 5 years ago
- Views:
Transcription
1 Cmmercialisatin f nanmaterials: prcess, issues, and management June 7, 2017 Taking a nan-based medical prduct t the internatinal market
2 The Unmet Need The glbal incidence f breast cancer is 1.7m annually and is the leading cause f cancer death in wmen Breast cancer incidence is prjected t reach 3.2m by 2030 due t cntinued demgraphic changes* When cancer is cnfirmed, it s stage must be established t decide nextsteps fr treatment T 1-4 N 0-3 M 0-1 system (Tumur, Ndes, Metastasis) Sentinel lymph nde bipsy (SLNB) is the best methd fr staging ndes Hwever, nly 1 in 6 patients glbally receives the gld-standard f care *Ginsburg, O. et al. The glbal burden f wmen s cancers. The Lancet (2016). di: /s (16)
3 Breast Cancer and Lymphatics When a tumur spreads, its cells are carried away by the interstitial fluid f the lymphatic system Axillary lymph nde dissectin (ALND) was the riginal surgical methd fr determining whether cancer had spread Arund 30 lymph ndes were surgically remved fr histlgical examinatin
4 NSABP B-32 Trial (May 1999 t Feb 2004) A sentinel lymph nde bipsy (SLNB) is where nly 1-2 lymph ndes are remved and analysed The Lancet, Octber 2010: Results frm 5,611 wmen acrss 80 Nrth American institutins Cnfirmed equivalent survivability at 5 years between patients with SLNB and thse with ALND established SLNB as the gldstandard f care
5 SLNB is superir fr patients Surgical cmplicatins Lymphedema at 5 years (subjective assessment) Lymphedema at 5 years (bjective assessment) Decreased range f mtin at 5 years Axillary paresthesia at 5 years Incidence 0% 20% 40% 60% 80% 100% Axillary clearance Sentinel nde bipsy Surgical cmplicatins including wund infectins and sermas greatly reduced with SLNB versus axillary clearance 1 Key measures f mrbidity five years after surgery als all significantly lwer fr SLNB 2 1. Lucci, A, et al. Surgical Cmplicatins Assciated With Sentinel Lymph Nde Dissectin (SLND) Plus Axillary Lymph Nde Dissectin Cmpared With SLND Alne in the American Cllege f Surgens Onclgy Grup Trial Z0011, JCO August 20, 2007 vl. 25 n Teshme M, Ballman KV, McCall LM, et al: Lng-term incidence f lymphedema after sentinel lymph nde dissectin fr early stage breast cancer: ACOSOG Z0010 (Alliance) SSO Cancer Sympsium.
6 The Availability Issue The traditinal technique injects a radiistpe that is filtered ut by the nde, and then lcated using a gammaray detecting prbe Hwever, radiistpes limit availability: Unreliable supply chain Shrt 6-hur half-life Subptimal wrkflw
7 Radiistpe Shrtage Apr 2014 OECD Reprt n the supply f medical radiistpes In Eurpe, prcessing capacity is particularly limited Glbal prcessing capacity is insufficient t ensure secure supply f 99 M/ 99m Tc in the perid thrugh 2020
8 Endmag s Plan Replace the radiistpe-labelled cllid with a magnetic nanparticle f similar dimensins Remves a material with a half-life, imprving availability and wrkflw Reduces radiactivity frm the OR and hspital waste stream Prvides the ptential fr a reliable and rbust supply chain Replace the gamma-ray detectin prbe with a magnetic prbe t lcate the magnetic nanparticles taken by the sentinel lymph ndes
9 System Requirements Our target: T meet the clinical need, we needed t detect 100 µg f a nanparticulate magnetic tracer at a distance f 20 mm frm the tip f a handheld prbe Our calculatins: We required a stimulated respnse (susceptmetry), and the ability t discern a 60 pt change n tp f a magnetising field f 50 µt a 1 ppm challenge
10 Sentimag Sentimag s handheld prbe is directinal, and indicates prximity by an increase in signal value and audi pitch Received CE mark apprval in Dec 2010
11 Early Develpment Crisis Irn xide MRI cntrast agents varied frm market t market acrss the wrld Mre cncerning was that irn xide agents started disappearing frm the market due t cmpetitin with gadlinium and, by Jan 2011, the nly agent available in the EU was discntinued Endmag needed t develp smething quickly! Bnus challenge: all MRI cntrast enhancement agents are regulated as drugs
12 What We Knew Dextran-cated irn xide nanparticles were retained in the lymph nde sinuses Particles didn t appear t transit t higher echeln ndes (~100nm diameter) But, the rate f transit t the first nde was nt ideal fr impatient surgens
13 Nanparticle Selectin Endmag investigated lymph nde sinus structure and identified an ideal diameter in the range f 40-80nm Missin was t develp r surce a sub-22nm irn xide particle with a bicmpatible cating that increased its diameter t ~60nm Ultimately surced a material that had a lng safety histry, but as an MRI cntrast agent a drug
14 Regulatry Challenges All MRI cntrast enhancement agents are regulated as drugs Hwever, Article 1(2)(a) f the Medical Device Directive 93/42/EEC (MDD) suggested that Sienna culd be classed as a medical device as it achieves its primary intended actin withut emplying pharmaclgical, immunlgical r metablic means Endmag initiated a pre-clinical investigatin t evaluate the mechanism f transprt and retentin in the lymph nde Magnetic signal at draining lymph nde vs time after injectin f Sienna at the third inguinal papilla in a prcine mdel
15 Mechanism f Actin Due t its particle size, Sienna+ is taken up int lymphatic vessels with the nrmal flw f lymph and flws t the lymph ndes Pre-clinical and clinical studies shwed transit t the nde in minutes. Only free transprt culd accunt fr this rapid uptake. Cell trafficking experiments shwed peripheral immune cells reaching the ndes nly after a number f hurs at the earliest.
16 Sienna+ Apprval Eurpe In Jul 2011, the MHRA agreed that Sienna culd prceed fr evaluatin as a Class IIa medical device Successful frmulatin, manufacturing and technical file audit supprted CE apprval in Dec 2011 making Sienna the first marketed nanparticle medical device
17 Manufacturing Challenges With CE apprvals in hand, clinical trials started in Feb 2012 On Mar 2 nd, the Sienna+ packager stated that the 6-mnth accelerated stability tests had failed visual inspectin due t particulates bserved by tw analysts Trial was halted while the nature and rt cause f the particulates was investigated An independent test huse cnfirmed the particulates were cttn/rayn fibres, and rt cause analysis indicated the likely surce was the packagers prcess The particulates were assessed as lw-risk as they were infrequent, nn-txic and the sterility f Sienna+ was nt cmprmised Ntified bdy accepted inclusin f pre-injectin filtratin needles
18 Sienna+ Apprval USA In Sep 2013, the FDA als accepted a device primary mde f actin, paving the rute t an Investigatinal Device Exemptin (IDE) and a multi-site pivtal trial that cmpleted in Dec 2015 PMA review is underway, and Sienna+ is likely t be the first apprved nanparticle medical device in the US later in 2017
19 Sienna+ Designed fr sentinel nde lcalizatin Magnetic nanparticles ptimized fr lymph nde uptake regulated as a device Reslves availability f the standard f care Imprves prcedural cnvenience Puts the surgen in cntrl Over 20,000 breast cancer prcedures perfrmed CE, CMDCAS and ARTG apprved FDA PMA expected late 17* *USA: Sienna+/Sentimag are limited t investigatinal use nly under an FDA-apprved IDE
20 Clinical Summary Results summary including >1,000 breast cancer patients
21 Epilgue Headquartered in Cambridge after spinning ut frm UCL and the University f Hustn in 2007 Revenue-stage with multi-digit grwth ver last 4 years, fllwing investments ttaling 9m Nrth America (Jul 2016) 2016 sales at 1.6m via strategic distributin partnerships, with 2017 cmmitted at ~ 4m Treated >20,000 breast cancer patients acrss 30 cuntries since launching in Nv 2012 EMEA (Feb 2013) Expanding internatinal IP prtfli f 15 patent families with 11 patents currently granted
22 Thank Yu Q & A
INTERIM REPORT JANUARY SEPTEMBER 2017
INTERIM REPORT JANUARY SEPTEMBER 2017 TELEPHONE CONFERENCE NO ONE SHOULD HAVE TO DIE WAITING FOR A NEW ORGAN Octber 27, 2017 MAGNUS NILSSON, CEO CHRISTOFFER ROSENBLAD, CFO NASDAQ OMX Stckhlm (mid cap):
More informationThis clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study Synpsis fr Public Disclsure This clinical study synpsis is prvided in line with Behringer Ingelheim s Plicy n Transparency and Publicatin f Clinical Study Data. The synpsis which is
More informationREPORT ON OPERATIONS 2017 TELEPHONE CONFERENCE
REPORT ON OPERATIONS 2017 TELEPHONE CONFERENCE NO ONE SHOULD HAVE TO DIE WAITING FOR A NEW ORGAN February 12, 2018 MAGNUS NILSSON, CEO CHRISTOFFER ROSENBLAD, CFO NASDAQ OMX Stckhlm (mid cap): XVIVO HIGHLIGHTS
More informationP02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017
P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin Revisin 1.9 July 26, 2017 P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin TABLE OF CONTENTS TABLE OF CONTENTS...
More informationCommissioning Policy: South Warwickshire CCG (SWCCG)
Cmmissining Plicy: Suth Warwickshire CCG (SWCCG) Treatment Indicatin Criteria FreeStyle Libre Flash Cntinuus Glucse Mnitring System Type I Diabetes Prir apprval must be requested frm the Individual Funding
More informationCONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW
FACT SHEET CONTACT: Amber Hamiltn 212-266-0062 TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW Type 2 diabetes accunts fr 90-95% f the 29.1 millin diabetes cases in the U.S. 1 Obesity is a majr independent
More informationHospital Preparedness Checklist
Hspital Preparedness Checklist http://pandemicflu.gv Preparedness Subject 1. Structure fr planning and decisin making An internal, multidisciplinary planning cmmittee fr influenza preparedness has been
More informationBreast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)
Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages
More informationACRIN 6666 Screening Breast US Follow-up Assessment Form
Screening Breast US Fllw-up Assessment Frm N. Instructins: The frm is cmpleted at 12, 24 and 36 mnths pst initial n study mammgraphy and ultrasund by the Radilgist r RA. Reprt all interim infrmatin related
More information23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)
Intrductin & Aims Drug and Alchl Cnsultatin Liaisn (AOD CL) services aim t imprve identificatin and treatment f patients with AOD mrbidity. The csts and cnsequences f targeting AOD patients presenting
More informationIndependent Charitable Patient Assistance Program (IPAP) Code of Ethics
Independent Charitable Patient Assistance Prgram (IPAP) Cde f Ethics Independent charitable patient assistance prgrams (IPAPs) fcus n the needs f patients wh are insured, meet certain financial limitatin
More informationIntravascular Catheters Market Size, Share & Trends Analysis Report and Segment Forecast, 2025 Grand View Research, Inc
Intravascular Catheters Market Size, Share & Trends Analysis Reprt and Segment Frecast, 2025 Grand View Research, Inc The glbal intravascular catheters market size was valued at USD 4.1 billin in 2018
More informationRefining Blood Collection Techniques to Improve Animal Welfare and Sample Quality
Refining Bld Cllectin Techniques t Imprve Animal Welfare and Sample Quality Amy Allaire RLATG 1, Jennifer Jhnsn 2, Kimberly Maratea DVM PhD 2, Steven Bulé CMAR RLATG 1, Sara Savage DVM DACLAM 1 1 Dispsitin,
More informationSUMMARY THE EUROPEAN COMMUNITY STRATEGY
SUMMARY THE EUROPEAN COMMUNITY STRATEGY FOR THE PHASEOUT OF CFCS IN MDIS 1. The Eurpean Cmmunity s transitin strategy fr the phaseut f CFCs in metered-dse inhalers (MDIs) was submitted t the Parties t
More information2017 CMS Web Interface
CMS Web Interface PREV-5 (NQF 2372): Breast Cancer Screening Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY
More informationPREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland
AWARD NUMBER: W81XWH-14-1-0444 TITLE: Culd HER2 Hetergeneity Open New Therapeutic Optins in Patients with HER2- Primary Breast Cancer? PRINCIPAL INVESTIGATOR: Gary Ulaner, MD, PhD CONTRACTING ORGANIZATION:
More informationSwindon Joint Strategic Needs Assessment Bulletin
Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical
More informationFDA Dietary Supplement cgmp
FDA Dietary Supplement cgmp FEBRUARY 2009 OVERVIEW Summary The Fd and Drug Administratin (FDA) has issued a final rule regarding current gd manufacturing practices (cgmp) fr dietary supplements that establishes
More informationPhotomedicine Devices And Technologies Market Size, Share & Trends Analysis Report and Segment Forecast, 2024 Grand View Research, Inc
Phtmedicine Devices And Technlgies Market Size, Share & Trends Analysis Reprt and Segment Frecast, 2024 Grand View Research, Inc The glbal phtmedicine devices and technlgies market accunted fr USD 314.9
More informationA fake medicine that passes itself off as a real, authorised medicine. (1)
Falsified medicines Index 1 Intrductin 2 Types f falsified medicines 3 Eurpean regulatin n falsified medicines 4 Risks f falsified medicines 5 Buying medicine nline safely 6 References 7 Further resurces
More informationCDC Influenza Technical Key Points February 15, 2018
CDC Influenza Technical Key Pints In this dcument: Summary Key Pints U.S. Vaccine Effectiveness U.S. Flu Activity Update Summary Key Pints On Thursday, tw influenza-related reprts appeared in the Mrbidity
More informationCONSENT FOR KYBELLA INJECTABLE FAT REDUCTION
CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,
More information2017 CMS Web Interface
CMS Web Interface CARE-2 (NQF 0101): Falls: Screening fr Future Fall Risk Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION...
More informationField Epidemiology Training Program
Field Epidemilgy Training Prgram Cancer Curriculum: Principles f Cancer Registries Case Study: Hspital-Based Cancer Registries FACILITATOR GUIDE FETP Cancer Curriculum: Principles f Cancer Registries Case
More informationUNIT 2: mapping bananas
Oxfam Educatin www.xfam.rg.uk/educatin UNIT 2: mapping bananas Age range: 7-11 years Outline Learners will investigate sme f the cuntries where the bananas we eat in the UK are grwn. They will first lcate
More informationTranscatheter Embolization And Occlusion Devices Market Size, Share & Trends Analysis Report and Segment Forecast, 2026 Grand View Research, Inc
Transcatheter Emblizatin And Occlusin Devices Market Size, Share & Trends Analysis Reprt and Segment Frecast, 2026 Grand View Research, Inc The glbal Transcatheter Emblizatin and Occlusin (TEO) devices
More informationRate Lock Policy. Contents
Rate Lck Plicy Cntents Rate Lcks... 2 Rate Lck Cnfirmatin... 2 Lck Term... 2 Pre-Lck... 2 Maximum Qualified Rate... 3 Extensins... 3 Cst t Extend... 3 Relcks... 4 Re-Negtiatin r Flat Dwn Plicy... 4 Prgram
More informationSafety of HPV vaccination: A FIGO STATEMENT
FIGO Statement n HPV Vaccinatin Safety, August 2nd, 2013 Safety f HPV vaccinatin: A FIGO STATEMENT July, 2013 Human papillmavirus vaccines are used in many cuntries; glbally, mre than 175 millin dses have
More informationThe estimator, X, is unbiased and, if one assumes that the variance of X7 is constant from week to week, then the variance of X7 is given by
ESTIMATION PROCEDURES USED TO PRODUCE WEEKLY FLU STATISTICS FROM THE HEALTH INTERVIEW SURVEY James T. Massey, Gail S. Pe, Walt R. Simmns Natinal Center fr Health Statistics. INTRODUCTION In April 97, the
More informationImaging tests allow the cancer care team to check for cancer and other problems inside the body.
IMAGING TESTS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between yu
More informationHEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights.
HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING Public Health Relevance Cervical cancer is 90% preventable by having regular Papaniclau (Pap) tests. The Pap test, als knwn as a cervical smear,
More informationThe clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.
The clinical trial infrmatin prvided in this public disclsure synpsis is supplied fr infrmatinal purpses nly. Please nte that the results reprted in any single trial may nt reflect the verall ptential
More informationAngiography Devices Market Size, Share & Trends Analysis Report and Segment Forecast, 2026 Grand View Research, Inc
Angigraphy Devices Market Size, Share & Trends Analysis Reprt and Segment Frecast, 2026 Grand View Research, Inc The glbal angigraphy devices market size was valued at USD 9.8 billin in 2018 and is prjected
More informationDATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS
DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 216 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS This briefing has been specifically prepared fr the Ministry f Health t prvide infrmatin frm this
More informationLTCH QUALITY REPORTING PROGRAM
4 LTCH QUALITY REPORTING PROGRAM GENERAL INFORMATION...3 LTCH FACILITY-LEVEL QUALITY MEASURE REPORT...5 LTCH PATIENT-LEVEL QUALITY MEASURE REPORT...18 LTCH REVIEW AND CORRECT REPORT...23 09/2018 v1.04
More informationCampus Climate Survey
Campus Climate Survey Executive Summary www.ecu.edu/ecyu 2016 A prject spnsred by the Office fr Equity and Diversity Executive Summary Prject Backgrund In FY 2013-2014, the Campus Climate Cmmissin prpsed
More informationSolid Organ Transplant Benefits to Change for Texas Medicaid
Slid Organ Transplant Benefits t Change fr Texas Medicaid Infrmatin psted February 13, 2015 Nte: All new and updated prcedure cdes and their assciated reimbursement rates are prpsed benefits pending a
More informationSports Nutrition Industry Across Different Regional Markets
Sprts Nutritin Industry Acrss Different Reginal Markets Supplements, the gd, the bad & the ugly China Internatinal Sprts Nutritin Industry Summit 2017 September 6 th, 2017 Mr. Jack Sehgal Directr, Business
More information2017 CMS Web Interface
CMS Web Interface PREV-6 (NQF 0034): Clrectal Cancer Screening Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY
More informationPress Release. Adocia: Activity and results for the first half of 2013
Press Release Adcia: Activity and results fr the first half f 2013 Intensificatin f R&D activity ahead f the launch f three clinical trials fr insulin prjects, starting in the secnd half f 2013 Net result
More informationRetinal Surgery Devices Market Size, Share & Trends Analysis Report and Segment Forecast, 2025 Grand View Research, Inc
Retinal Surgery Devices Market Size, Share & Trends Analysis Reprt and Segment Frecast, 2025 Grand View Research, Inc The glbal retinal surgery devices market size was estimated at USD 1.56 billin in 2016
More informationEvaluation of Hunter & New England HealthPathways
Evaluatin f Hunter & New England HealthPathways 2 General Practice & Ambulatry Care Activity General Practice MBS data: In 2013 there were 3.3 millin patient attendances t 730 GPs in the HML regin, a 5.6%
More informationService Change Process. Gateway 1 High-level Proposition. Innovation project name: Patient Self-Monitoring/Management of Warfarin
Service Change Prcess Gateway 1 High-level Prpsitin Innvatin prject name: Patient Self-Mnitring/Management f Warfarin NHS Bury Please describe the service change being prpsed. Please describe what service(s)
More informationVolume Measurement at CT
Vlume Measurement at CT Staging and Assessment f Respnse with Quantitative CT Lawrence Schwartz, MD Department f Radilgy Clumbia University Cllege f Physicians and Surgens LSCHWARTZ@COLUMBIA.EDU Recmmendatins
More informationImproving Treatment Rates of Cervical Precancers Detected through Visual Screening in Cameroon, West Africa.
Imprving Treatment Rates f Cervical Precancers Detected thrugh Visual Screening in Camern, West Africa. X. Yu a, E. Welty b, T. Welty b, B. Futuh c, K. Nulah b, S. Manga b, C. Sirri b and A. Zier c. a
More informationImplementation of G6PD testing and radical cure in P. vivax endemic countries: considerations
Implementatin f G6PD testing and radical cure in P. vivax endemic cuntries: cnsideratins Malaria Plicy Advisry Cmmittee Geneva, Switzerland 16-18 September 2015 1 WHO Guidelines n Radical Cure WHO guidelines
More informationAP Biology Lab 12: Introduction to the Scientific Method and Animal Behavior
Name: AP Bilgy Lab 12: Intrductin t the Scientific Methd and Animal Behavir Overview In this lab yu will: -Observe an rganism and design an experiment t investigate their respnses t envirnmental variables.
More informationRisk factors in health and disease
Risk factrs in health and disease Index 1 Intrductin 2 Types f risk factrs 2.1 Behaviural risk factrs 2.2 Psychlgical risk factrs 2.3 Demgraphic risk factrs 2.4 Envirnmental risk factrs 2.5 Genetic risk
More informationApril 23, 2008 Information Sheet: Safety of BPA-derived Can Liners. Summary
April 23, 2008 Infrmatin Sheet: Safety f BPA-derived Can Liners Summary The use f bisphenl A (BPA)-derived epxy resins t make prtective catings fr metal fd and beverage packaging helps prvide safe, whlesme
More informationInterpretation. Historical enquiry religious diversity
Name: Year 8 Histry Prject 3: D The Cmmnwealth Games Still Matter In The 21 st Century? Mdule: Date Set: Deadline: Descriptin f the task: The prject is split int three separate parts: The prject is split
More informationA Unified Approach to Conflict Mineral Compliance for the Tungsten Industry. The Westin, Sydney, 23 September 2013
A Unified Apprach t Cnflict Mineral Cmpliance fr the Tungsten Industry The Westin, Sydney, 23 September 2013 Backgrund Cmpliance f public US dwnstream tungsten users with the reprting requirements f the
More informationMaterials Dissecting pan, dissecting kit, safety glasses, lab apron, pig heart, & gloves
Heart Dissectin Intrductin Mammals have fur-chambered hearts and duble circulatin. The heart f a bird r mammal has tw atria and tw cmpletely separated ventricles. The dublelp circulatin is similar t amphibians
More informationPHARYNGO-OESOPHAGECTOMY
PHARYNGO-OESOPHAGECTOMY This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins
More informationLyme Disease Surveillance in North Carolina
Lyme Disease Surveillance in Nrth Carlina 2008-2014 Carl Williams DVM Megan Sanza MPH Cmmunicable Disease Branch Divisin f Nrth Carlina Public Health Lyme Disease Surveillance in Nrth Carlina 2008-2014
More informationImproving Surveillance and Monitoring of Self-harm in Irish Prisons
HSE Mental Health Divisin Stewart s Hspital, Palmerstwn, Dublin 20 Tel: 01 6201670 Email: inf@nsp.ie www.nsp.ie Imprving Surveillance and Mnitring f Self-harm in Irish Prisns Prject Scpe Dcument 8 th June
More informationSpecifically, on page 12 of the current evicore draft, we find the statement:
Octber 23, 2016 evicre Healthcare Attn: Dr Greg Allen 400 Buckwalter Place Bulevard Blufftn, SC 29910 RE: evicre Draft Onclgy Imaging Guidelines, v 19.0 Gentlepersns: Prstate Cancer Internatinal is a nt-fr-prfit
More informationD E R B Y, D E R B Y S H I R E, N O T T I N G H A M & N O T T I N G H A M S H I R E L M I S U M M A R Y
D E R B Y, D E R B Y S H I R E, N O T T I N G H A M & N O T T I N G H A M S H I R E L M I S U M M A R Y 2 A B O U T This dcument prvides a summary f key findings fr the Derby, Derbyshire, Nttingham and
More informationUniversal IC Attachment
Universal IC Attachment www.preat.cm 800-232-7732 IC Universal Attachment Universal Male: 5.2mm length, 2mm Ø, 1mm nse Packaged Individually Indicatins: Esthetic partial dentures (n buccal clasp required)
More informationFrequently asked questions: Influenza A (H1N1)v
July 30 th 2009 V1.0 Frequently asked questins: Influenza A (H1N1)v (Swine Flu) infrmatin fr parents The fllwing advice is fr parents f children in all educatinal institutins, including crèches, childcare,
More informationctdna-guided Change of Therapy Improves Quality of Life of a Lung Cancer Patient
CASE STUDY ctdna-guided Change f Therapy Imprves Quality f Life f a Lung Cancer Patient Quick Summary Tripti Vasudev*, aged 61 years, was diagnsed with NSCLC. Genetic analysis revealed the presence f an
More information1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT
WOMEN AND NEWBORN HEALTH SERVICE CLINICAL GUIDELINES SECTION A: GUIDELINES RELEVANT TO OBSTETRICS AND GYNAECOLOGY 1 STANDARD PROTOCOLS 1.11 INSULIN INFUSION PUMP MANAGEMENT - INPATIENT Authrised by: OGCCU
More informationBariatric Surgery FAQs for Employees in the GRMC Group Health Plan
Bariatric Surgery FAQs fr Emplyees in the GRMC Grup Health Plan Gergia Regents Medical Center and Gergia Regents Medical Assciates emplyees and eligible dependents wh are in the GRMC Grup Health Plan (Select
More informationThis standard operating procedure applies to stop smoking services provided by North 51.
Authr Name/Title Melanie McIlvar, Bid Develpment Manager Authr Signature Date: 4 th September 2017 Apprver Name/Title Jasn Shelley, Grup Directr f QA/RA Apprver Signature Date: 4 th September 2017 Issue
More informationResponse to. type 2 vaccine-derived polioviruses. prior to global topv withdrawal. Interim Guidelines
Respnse t type 2 vaccine-derived pliviruses prir t glbal topv withdrawal Interim Guidelines August 2015 GPEI peratinal guidance nte August 2015 Summary Prepare fr prmpt actin fr any area r ppulatin at
More informationTrauma Devices Market Size, Share & Trends Analysis Report and Segment Forecast, 2025 Grand View Research, Inc
Trauma Devices Market Size, Share & Trends Analysis Reprt and Segment Frecast, 2025 Grand View Research, Inc The glbal trauma devices market size was valued at arund USD 6.9 billin in 2017 and is anticipated
More informationWork Experience - Athletic Training. o Work Experience, General. o Open Entry/Exit. Distance (Hybrid Online) for online supported courses
SECTION A - Curse Infrmatin 1. Curse ID: 2. Curse Title: 3. Divisin: 4. Department: 5. Subject: 6. Shrt Curse Title: 7. Effective Term:: KIN 92 Wrk Experience - Athletic Training Kinesilgy & Athletics
More informationProtocol. Preparation Protocol for the Non-Targeted Vevo MicroMarker Contrast Agent
Prtcl Preparatin Prtcl fr the Nn-Targeted Vev MicrMarker Cntrast Agent System Cmpatibility: This guide cntains instructins and suggestins fr wrk n the Vev2100, VevLAZR, Vev 3100 systems and transducers
More informationPost Distribution Monitoring Report
Pst Distributin Mnitring Reprt Hygiene Kit funded by IMC Backgrund Infrmatin Lcatin: Zaatari Camp (All districts) Dates f data cllectin: 1-2 f Octber, 2014 Objective: t understand t what extent the distributin
More informationEXECUTIVE SUMMARY INNOVATION IS THE KEY TO CHANGING THE PARADIGM FOR THE TREATMENT OF PAIN AND ADDICTION TO CREATE AN AMERICA FREE OF OPIOID ADDICTION
EXECUTIVE SUMMARY INNOVATION IS THE KEY TO CHANGING THE PARADIGM FOR THE TREATMENT OF PAIN AND ADDICTION TO CREATE AN AMERICA FREE OF OPIOID ADDICTION The Bitechnlgy Innvatin Organizatin (BIO) and ur member
More informationWHAT IS HEAD AND NECK CANCER FACT SHEET
WHAT IS HEAD AND NECK CANCER FACT SHEET This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice
More informationAction plan: serialisation of Nordic packages focus on Product Codes
19.6.2017, versin 5 Actin plan: serialisatin f Nrdic packages fcus n Prduct Cdes The aim f this dcument is t help pharma cmpanies t prepare fr prduct cde changes and t be able t maintain prduct cdes in
More information2017 Optum, Inc. All rights reserved BH1124_112017
1) What are the benefits t clients f encuraging the use f MAT? Withut MAT, 90% f individuals with Opiid Use Disrder (OUD) will relapse within ne year. With MAT, the relapse rate fr thse with OUD decreases
More informationMalaria 2025: Accelerate to Eliminate The Global Technical Strategy for Malaria: Setting global targets Azra Ghani, GTS Steering Committee
Malaria 2025: Accelerate t Eliminate The Glbal Technical Strategy fr Malaria: 2016-2025 Setting glbal targets Azra Ghani, GTS Steering Cmmittee Geneva, 12 March 2014 1 Visin and Gals Purpse f Visin and
More informationWound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018
Wund Care Equipment and Supply Benefits t Change fr Texas Medicaid July 1, 2018 Infrmatin psted May 11, 2018 Nte: Texas Medicaid managed care rganizatins (MCOs) must prvide all medically necessary, Medicaid-cvered
More informationTOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH
Tpic Circulatin list In case f query please cntact Executive Summary TOP TIPS Lung Cancer Update Dr Andrew Wight Cnsultant respiratry Physician - WUTH All Wirral GP s JaneFletcher2@nhs.net Dear Clleagues,
More informationThe data refer to persons aged between 15 and 54.
Drug-related hspital stays in Australia 1993-2005 Prepared by Amanda Rxburgh and Luisa Degenhardt, Natinal Drug and Alchl Research Centre Funded by the Australian Gvernment Department f Health and Ageing
More informationHuman papillomavirus (HPV) refers to a group of more than 150 related viruses.
HUMAN PAPILLOMAVIRUS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between
More informationThe Shea Supply Chain and its Value in Confectionery Products. GSA New York May 2014
The Shea Supply Chain and its Value in Cnfectinery Prducts. GSA New Yrk May 2014 IOI Lders Crklaan is part f IOI Grup Prperty develpment Oil palm plantatins Olechemicals Edible Oils (including IOI Lders
More informationCDC Influenza Division Key Points MMWR Updates February 20, 2014
CDC Influenza Divisin Key Pints MMWR Updates In this dcument: Summary Key Messages Seasnal Influenza Vaccine Effectiveness: Interim Adjusted Estimates Influenza Surveillance Update: September 29, 2013-February
More informationneuropharmaceuticals commericalization
neur neurpharmaceuticals cmmericalizatin neurnan pharma 11th Annual NanBusiness Cnference Nanmanufacturing Summit September 4-6, 2012 Bstn, MA neur I. Intrductin 2 Alexander Kabanv, C-funder UNC - Chapel
More informationElectrosurgical Devices Market Size, Share & Trends Analysis Report and Segment Forecast, 2025 Grand View Research, Inc
Electrsurgical Devices Market Size, Share & Trends Analysis Reprt and Segment Frecast, 2025 Grand View Research, Inc Grwing awareness regarding mst recent surgical techniques in develping regins is expected
More informationTick fever is a cattle disease caused by any one of the following blood parasites:
Tick fever Tick fever is a cattle disease caused by any ne f the fllwing bld parasites: Babesia bvis Babesia bigemina Anaplasma marginale These parasites are all transmitted by the cattle tick (Bphilus
More informationTriumeq (abacavir, dolutegravir and lamivudine) Product Backgrounder for US Media
Triumeq (abacavir, dlutegravir and lamivudine) Prduct Backgrunder fr US Media What is Triumeq and wh is Triumeq fr? Triumeq (abacavir 600mg, dlutegravir 50mg and lamivudine 300mg) is the first dlutegravir-based
More informationVCCC Research and Education Lead for Breast Cancer
VCCC Research & Educatin Lead VCCC Research and Educatin Lead fr VCCC Visin The Victrian Cmprehensive Cancer Centre (VCCC) will save lives thrugh the integratin f cancer research, educatin and clinical
More informationA. Catalonia World Health Organization Demonstration Project
A. Catalnia Wrld Health Organizatin Demnstratin Prject In 1989, the Health Department f Catalnia (Spain) and the Cancer Unit at the WHO (Geneva) designed and planned a demnstratin prject fr implementatin
More informationALCAT FREQUENTLY ASKED QUESTIONS
1. Is fasting required befre taking the Alcat Test? N. It is recmmended t drink water and t avid stimulants like caffeine prir t the test. 2. With regard t testing children, must a child be a certain age
More informationMethadone Maintenance Treatment for Opioid Dependence
POLICY STATEMENT Methadne Maintenance Treatment fr Opiid Dependence APPROVED BY COUNCIL: May 2010 PUBLICATION DATE: Dialgue, Issue 2, 2010 Disclaimer: As f May 19, 2018 physicians n lnger require an exemptin
More information2018 CMS Web Interface
CMS Web Interface Diabetes Mellitus (DM) Cmpsite (All r Nthing Scring) DM-2 (NQF 0059): Diabetes: Hemglbin A1c (HbA1c) Pr Cntrl (>9%) DM-7 (NQF Measure Steward: NCQA CMS Web Interface V2.1 Page 1 f 26
More informationThe U.S. & The Global Fund to Fight AIDS, Tuberculosis and Malaria
The U.S. & The Glbal Fund t Fight AIDS, Tuberculsis and Malaria The Glbal Fund t Fight AIDS, Tuberculsis and Malaria (Glbal Fund) is an independent, multilateral, financing entity designed t raise significant
More informationQUALITY AND SAFETY MEASURES UPDATE January 2016
CLINICAL EFFECTIVENESS/SAFETY M CORE MEASURES 2015 See attached Results QUALITY AND SAFETY MEASURES UPDATE January 2016 Jint Cmmissin and CMS Cre Measure Dashbard updated with mst recent data available:
More informationCognitive Processing for Interpreters. Humanities and Social Sciences Division. o Work Experience, General. o Open Entry/Exit
SECTION A - Curse Infrmatin 1. Curse ID: 2. Curse Title: 3. Divisin: 4. Department: SIGN 227 Cgnitive Prcessing fr Interpreters Humanities and Scial Sciences Divisin Sign Language Department 5. Subject:
More informationGuideline Number: NIA_CG_301 Last Revised Date: October 2014 Responsible Department: Implementation Date: October 2014 Clinical Operations
Natinal Imaging Assciates, Inc. Clinical guidelines PARAVERTEBRAL FACET JOINT INJECTIONS OR BLOCKS CPT Cdes: Cervical Thracic Regin: 64490 (+ 64491, +64492), 0213T (+0214T, +0215T) Lumbar Sacral Regin:
More informationHerbal Medicines: Traditional Herbal Registration
Herbal Medicines: Traditinal Herbal Registratin In the UK, cmpanies can nly sell herbal medicines with the apprpriate prduct licence, as fllws: A full marketing authrisatin based n the safety, quality
More informationChronic Fatigue Syndrome
Chrnic Fatigue Syndrme (Als knwn as Myalgic encephalmyelitis/encephalmyelpathy) What is CFS/ME? CFS/ME cmprises a range f symptms that include fatigue, malaise, headaches, sleep disturbances, difficulties
More informationEUROPEAN MEDICINES AGENCY DECISION. of 14 October 2008
Eurpean Medicines Agency Dc. Ref. EMEA/522876/2008 P/84/2008 EUROPEAN MEDICINES AGENCY DECISION f 14 Octber 2008 n the applicatin fr agreement f a Paediatric Investigatin Plan fr valsartan (Divan) (EMEA-000005-PIP01-07)
More informationWCPT awards programme 2015
WCPT awards prgramme 2015 The WCPT awards prgramme recgnises utstanding cntributins and leadership by individual physical therapists and grups t the prfessin and/r glbal health at an internatinal level.
More informationAndrew J. Lukaszewicz, MD Raffat Ahmad, MD Mary Maunglay, MD Sarah K. Shields, MD Dustin Covell, MD Cory Trivax, MD
Andrew J. Lukaszewicz, MD Raffat Ahmad, MD Mary Maunglay, MD Sarah K. Shields, MD Dustin Cvell, MD Cry Trivax, MD Nne f the authrs have any financial disclsures 1. Learn abut what digital breast tmsynthesis
More informationEXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS
1 SECTION 1 INTRODUCTION: EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS The Nature Of Assessment The Definitin Of Assessment The Difference Between Testing, Measurement And Evaluatin Characteristics
More information2017 CMS Web Interface
CMS Web Interface Diabetes Mellitus (DM) Cmpsite (All r Nthing Scring) DM-2 (NQF 0059): Diabetes: Hemglbin A1c (HbA1c) Pr Cntrl (>9%) DM-7 (NQF 0055): Diabetes: Eye Exam Measure Steward: NCQA Web Interface
More information